MarginsXMarginsX
Home › Markets › Health Care › GRML

Greenland Mines Ltd. (GRML)

GRML trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.50
-3.05% on the day
Market cap
$51.9M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerGRML on Nasdaq
SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
CountryUnited States
IPO year2022
SEC CIK0001907223
SEC industry codeBiological Products, (No Diagnostic Substances)

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
7.8 months
$9.3M cash at June 30, 2026
Share count, 1 year
+158.8%
2025-08-15 to 2026-08-17 · +1704.8% over 3 years
Going-concern doubt
Yes
10-Q filed August 17, 2026
Insider net buying, 12 months
$428K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Without additional funding, there is substantial doubt about the Company's ability to continue as a going concern for twelve months from the date these financial statements are issued."
10-Q 2026-08-17
Cash and burn$9.3M cash; operating cash flow -$3.6M a quarter.Report 2026-06-30
Shares outstandingNo cover-page share count in XBRLCover page 2026-08-17
Reverse splits, 3 years1; latest 1-for-50 on 2026-08-24Source 2026-08-24
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 6 424B5 takedowns, 5 at the marketLatest 2026-09-28
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBCRG Group, Irvine, California, United States; changed auditors 2 times in 24 months8-K 4.01 2026-07-08
Late filings, 12 months3 NT noticesNT 10-Q 2026-08-14
Insider trades, 12 monthsBought $468K, sold $40K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$3.7M-$6.9M$9.3MNo debt tagsNeeds four quarters10-Q 2026-08-17
Q1 2026
2026-03-31
Not filed-$13.9M-$5.0M$10.0MNo debt tagsNeeds four quarters10-Q 2026-08-17
Q4 2025
2025-12-31
Not filed-$1.3M-$1.3M$7.2MNo debt tagsNeeds four quarters10-K/A 2026-08-14
Q3 2025
2025-09-30
Not filed-$2.9M-$1.1M$7.3MNo debt tagsNeeds four quarters10-Q 2025-11-13
Q2 2025
2025-06-30
Not filed-$4.1M-$1.9M$8.4MNo debt tagsNeeds four quarters10-Q 2026-08-17
Q1 2025
2025-03-31
Not filed-$2.2M-$1.6M$566K$1.8MNeeds four quarters10-Q 2026-08-17
Q4 2024
2024-12-31
Not filed-$2.1M-$944K$64K$241KNeeds four quarters10-K/A 2026-08-14
Q3 2024
2024-09-30
Not filed-$3.0M-$1.1M$51KNo debt tagsNeeds four quarters10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
S-12026-10-26
Latest annual report
AMENDMENT NO. 1 TO FORM 10-K
10-K/A2026-08-14
Latest quarterly / interim10-Q2026-11-16
Latest current report
CURRENT REPORT
8-K2026-11-12
Latest proxy
PROXY STATEMENT
DEF 14A2026-06-22

Source: SEC EDGAR submissions feed, 272 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-6.0%
1 month-34.8%
3 months-64.6%
Year to date-75.0%
1 year-84.8%
From 52-week high-88.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
GRMLWGreenland Mines Ltd Warrant$0.2801

Peers in Biotechnology: Biological Products (No Diagnostic Substances)

TickerCompanyPriceDayMarket cap
ELOXEloxx Pharmaceuticals Inc.$12.75-3.04%$51.5M
INKTMiNK Therapeutics Inc.$9.35+0.11%$48.0M
PMCBPharmaCyte Biotech Inc.$5.57-16.62%$59.8M
CGTXCognition Therapeutics Inc.$0.6388-6.03%$60.8M
OKYOOKYO Pharma Limited$1.18-12.96%$61.7M
CSBRChampions Oncology Inc.$4.68-0.53%$65.1M
ATRAAtara Biotherapeutics Inc.$6.40-16.88%$65.2M
CRDFCardiff Oncology Inc.$0.8477+16.75%$65.9M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier